Soligenix

A stock ticker showing financial information
Biotech

Soligenix shares take another dip as FDA requests 2nd trial

After the FDA denied approval for Soligenix’s rare cancer treatment in February, the agency has now said a second clinical trial will be needed.
Gabrielle Masson Apr 14, 2023 11:02am
Food and Drug Administration

Soligenix stock sinks as FDA refuses lymphoma application

Feb 14, 2023 10:15am
Nasdaq

Soligenix's stock climbs as phase 3 lymphoma trial hits goal

Mar 19, 2020 9:00am